Entheon Biomedical Corp. (CSE: ENBI)

Entheon Biomedical Balance Sheet

Financials in millions CAD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	May 31, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019
Cash & Equivalents	0.3	0.34	0.68	2.05	2.79	0.11
Trading Asset Securities	-	-	-	-	0.05	-
Cash & Short-Term Investments	0.3	0.34	0.68	2.05	2.84	0.11
Cash Growth	-38.57%	-49.33%	-66.81%	-27.77%	2418.31%	-
Other Receivables	0	0.01	0.04	0.03	0.08	0
Receivables	0	0.01	0.04	0.03	0.08	0
Inventory	-	-	-	0.03	-	-
Prepaid Expenses	0.03	0.05	0.02	1.1	1.49	0.02
Total Current Assets	0.33	0.4	0.74	3.21	4.4	0.14
Property, Plant & Equipment	-	-	-	0.16	0.01	-
Long-Term Investments	-	-	-	0.7	0.06	-
Other Intangible Assets	-	-	-	5.9	-	-
Other Long-Term Assets	0.01	0.01	0.03	-	-	-
Total Assets	0.34	0.4	0.77	9.98	4.47	0.14
Accounts Payable	0.04	0.08	0.14	0.93	0.72	0.09
Accrued Expenses	0	0	0.02	-	0	0
Short-Term Debt	-	-	-	-	-	0
Total Current Liabilities	0.04	0.09	0.15	0.93	0.73	0.09
Total Liabilities	0.04	0.09	0.15	0.93	0.73	0.09
Common Stock	20.06	19.96	19.35	19.35	7.15	0.32
Retained Earnings	-21.48	-21.31	-21.61	-13.55	-4.66	-0.28
Comprensive Income & Other	1.71	1.66	2.87	3.24	1.26	0
Shareholders' Equity	0.29	0.32	0.61	9.05	3.74	0.04
Total Liabilities & Equity	0.34	0.4	0.77	9.98	4.47	0.14
Total Debt	-	-	-	-	-	0
Net Cash (Debt)	0.3	0.34	0.68	2.05	2.84	0.11
Net Cash Growth	-38.57%	-49.33%	-66.81%	-27.77%	2487.90%	-
Net Cash Per Share	0.05	0.06	0.12	0.38	1.03	0.26
Filing Date Shares Outstanding	8.86	5.91	5.91	5.91	4.04	2.98
Total Common Shares Outstanding	8.86	5.91	5.91	5.91	4.04	2.08
Working Capital	0.29	0.31	0.59	2.28	3.68	0.04
Book Value Per Share	0.03	0.05	0.10	1.53	0.93	0.02
Tangible Book Value	0.29	0.32	0.61	3.15	3.74	0.04
Tangible Book Value Per Share	0.03	0.05	0.10	0.53	0.93	0.02
Machinery	-	-	-	0.16	0.01	-
Leasehold Improvements	-	-	-	0.04	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.